The aim of this Global Allergy and Asthma European Network (GA(2)LEN) consensus report is to provide recommendations and suggestions for assessing patient-reported outcomes (PROs) including health-related quality of life in patients with urticaria. We recommend that PROs should be used both in clinical trials and routine practice for the evaluation of urticaria patients. We suggest that PROs should be considere...
The aim of this Global Allergy and Asthma European Network (GA2LEN) consensus report is to provide recommendations and suggestions for assessing patient-reported outcomes (PROs) including health-related quality of life in patients with urticaria. We recommend that PROs should be used both in clinical trials and routine practice for the evaluation of urticaria patients. We suggest that PROs should be considered ...
Foram determinados os valores de energia metabolizável aparente (EMA), de energia metabolizável aparente corrigida por retenção de nitrogênio (EMAn) e do coeficiente de metabolização aparente da energia bruta (CMAEB%) do milho, sorgo, farelo de soja, farelo de glúten de milho e óleo de soja refinado. Foram utilizadas 240 codornas japonesas (Coturnix japonica), fêmeas com idade inicial de 60 dias, em delineament...
The GA(2)LEN taskforce on Patient-Reported Outcomes (PROs) and Health-Related Quality of Life (HRQoL) published in 2009 a position paper concerning PROS and HRQoL assessment in clinical trials on allergy. Because of the specificity of this topic in asthma and rhinitis, specific recommendations are needed. The aim of this position paper is to define PROs and their meaning in asthma and rhinitis research, explore...
The aim of this GA2LEN consensus report is to provide recommendations for Patient-Reported Outcomes evaluation in clinical trials for allergic diseases, which constitute a global health problem in terms of physical, psychological, economic and social impact. During the last 40 years PROs have gained large consideration and use in the scientific community, in order to gain a better understanding of patients’ sub...
The GA2LEN taskforce on Patient-Reported Outcomes (PROs) and Health-Related Quality of Life (HRQoL) published in 2009 a position paper concerning PROS and HRQoL assessment in clinical trials on allergy. Because of the specificity of this topic in asthma and rhinitis, specific recommendations are needed. The aim of this position paper is to define PROs and their meaning in asthma and rhinitis research, explore t...
The aim of this Global Allergy and Asthma European Network (GA(2)LEN) consensus report is to provide recommendations for patient-reported outcomes (PROs) evaluation in clinical trials for allergic diseases, which constitute a global health problem in terms of physical, psychological economic and social impact. During the last 40 years, PROs have gained large consideration and use in the scientific community, to...
Determinaram-se os valores de energia metabolizável aparente (EMA) e energia metabolizável aparente corrigida por retenção de nitrogênio (EMAn) de sete alimentos testados em dietas para codornas japonesas. Utilizaram-se 280 codornas japonesas (Coturnix japonica) fêmeas, com idade inicial de 26 dias, em delineamento experimental inteiramente ao acaso, com cinco repetições e sete codornas por unidade experimental...
Avaliaram-se pastagens de capim-elefante e capim-mombaça, por intermédio de amostras de extrusa esofágica e simulação manual de pastejo, estimando-se a composição químico-bromatológica, o fracionamento dos compostos nitrogenados e carboidratos, e a digestibilidade in vitro da matéria seca. Foram utilizados 15 e 13 piquetes de capim-elefante e capim-mombaça, respectivamente, com período de ocupação de três dias....
Financiadores do RCAAP | |||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |